Skip to main content

TABLE 4.

Viremia in rhesus monkeys inoculated i.c. with YF-VAX or ChimeriVax JE FRhL3 and FRhL5 virusesa

Test virus Animal Serum virus titer (log10 PFU/mL) on day:
1 2 3 4 5 6 7 8 9
YF-VAX control RT702M b 1.6 3.0
RAH80F 3.3 2.5
RT758M 2.1 3.2 2.8
RAL02F 1.3
RT653M 2.7
RT698F 1.0 2.3 3.7 2.5 1.0
RT776M
RAI12F 2.0 2.5 2.5 2.0
RT621M 1.0 2.0 3.3 2.0
c>
RP942F 1.0 2.6 3.6 2.0
Meanc 0.8 1.4 2.7 1.7 0.9 0.9
SD 0.1 0.8 1.0 0.9 0.6 0.4
ChimeriVax-JE FRhL3, E279 Met RAJ98F 1.9 1.3
RT452M 1.3 2.1 1.6
RAR08F 1.3 2.2 2.2 1.8
RR257M 1.9 2.2 1.8
RV481F 2.1 1.8 1.5
RT834M 2.5 1.3
RT841F 2.4 1.7
RT620M 1.6 1.0
RT392F
RT288M
Mean 0.8 1.7 1.5 1.0 0.8
SD 0.2 0.6 0.5 0.6 0.3
P valued 0.696 0.386 0.003 0.065 0.745
ChimeriVax-JE FRhL5 E279 Lys RT628M
RAJ55F
RT678M
RT769F 2.0
RT581M
RAK22F 1.8
RR726M
RT207F
RR725M
RT490F
Mean 0.7 0.7 0.8 0.7 0.7 0.8
SD 0.0 0.0 0.4 0.0 0.0 0.4
P valuee 0.331 <0.000 0.010 0.076 1.0 1.0
a

For the dose inoculated, see Table 3. In most tests undiluted serum was tested, with the cutoff being 1.0 log10 PFU/ml, in some cases, undiluted serum was toxic to cells, and serum diluted 1:2 or 1:5 was used (cutoff, 1.3 or 1.7 log10 PFU/ml).

b

—, no detectable viremia.

c

For the purpose of calculating mean titers and standard deviations, 0.7 was used in place of<1.0, 1.0 was used in place of <1.3, and 1.4 was used in place of <1.7.

d

Comparison with YF-VAX by two-tailed t test.

e

Comparison with ChimeriVax-JE FRhL3 by two-tailed t test.